Intermediate Risk Prostate Cancer: Disease Heterogeneity Linked to Measurable Biological Features

Clinical Oncology - United Kingdom
doi 10.1016/j.clon.2019.11.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Insignificant Disease Among Men With Intermediate-Risk Prostate Cancer

World Journal of Urology
Urology
2014English

Active Surveillance in Intermediate Risk Prostate Cancer: Is It Safe?

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2016English

Expending the Paradigm: Active Surveillance for Intermediate Risk Prostate Cancer

Open Journal of Urology
2018English

Mp18-07 Applicability Analysis of Focal Therapy to Intermediate- And High-Risk Prostate Cancer

Journal of Urology
Urology
2016English

Prostate Cancer Predisposition Loci and Risk of Metastatic Disease and Prostate Cancer Recurrence

Clinical Cancer Research
Cancer ResearchOncology
2011English

Intermediate Risk Prostate Cancer Patients Treated With Image Guided Hypofractionated Radiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Hypofractionated Stereotactic Body Radiation Therapy as Monotherapy for Intermediate-Risk Prostate Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2013English

Successful Phase 2 Trial of Ultrafocal Brachytherapy for Low/Intermediate Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Ultrahypofractionation Should Be a Standard of Care Option for Intermediate-Risk Prostate Cancer

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy